The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and ...

Urticaria or hives is a skin condition causing itchy red welts from various triggers Read ahead know its symptoms and why it often worsen at night ...

Urticaria highlights from AAD 2025 include late-breaking results from a phase 1b/2a study of the anti-c-Kit antibody ...

Adults with chronic spontaneous urticaria experienced greater mortality, probably due to increased risks for comorbidities, ...

Medically reviewed by Femi Aremu, PharmD Skin rashes can have many different causes, one of which is medications. The ...

Dr Adam Friedman discusses the clinical impact of CSU updates, highlighting emerging therapies, dietary insights, and patient ...

Patients with chronic spontaneous urticaria typically receive second-generation H 1-antihistamines as first-line therapy, but more than 50% continue to have symptoms. New research findings on ...

Morgan Stanley has initiated Celldex Therapeutics (NASDAQ:CLDX) at overweight saying that barzolvolimab (barzol), its asset for chronic urticaria (CU), is poised to become a major revenue ...

SAN DIEGO — Patients with chronic spontaneous urticaria that was not controlled with H1 antihistamines experienced improvements in itch and urticaria activity with dupilumab, according to a ...

Loratadine, a widely prescribed second-generation antihistamine, is commonly used to treat allergic conditions such as hay ...